Brief: Egetis Therapeutics Q4 Loss Narrows To SEK 32.1 Mln
Feb 17 (Reuters) - Egetis Therapeutics AB (publ) EGTX.ST :
* Q4 QUARTERLY NET REVENUE MSEK 3.5 (5.3)
* Q4 LOSS MSEK -32.1 (-74.3)
Source text for Eikon: ID:nMFN8KfnQM
Further company coverage: EGTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1